Additionally, the dysregulation of GSK3β has been linked with the cognitive abnormalities and pathologies of AD [16], schizophrenia [17], fragile-X mental retardation [18,19], mood disorders [20,21], ischemic stroke and other excitotoxicity-related disorders [22]. The gene discussed is GSK3B; the disease is Alzheimer disease.